Deep sea water modulates blood pressure and exhibits hypolipidemic effects via the AMPK-ACC pathway: An in Vivo study

Marine Drugs

Volumn 11, Issue 6, 2013, Pages 2183-2202

  Sheu, Ming Jyh ^a   Chou, Pei Yu ^a   Lin, Wen Hsin ^a   Pan, Chun Hsu ^a   Chien, Yi Chung ^a   Chung, Yun Lung ^a   Liu, Fon Chang ^a,b   Wu, Chieh Hsi ^a  

^a CHINA MEDICAL UNIVERSITY   (Taiwan)

^b Department of Physical Therapy and Rehabilitation Rehabilitation Assistive Device Center Da Chien General Hospital   (Taiwan)

Author keywords

Acetyl CoA carboxylase; AMP activated protein kinase; Atherosclerosis; Deep sea water; HMG CoA reductase

Indexed keywords

ACETYL COENZYME A CARBOXYLASE; DEEP SEA WATER; DRINKING WATER; FATTY ACID; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; LIPID; MAGNESIUM CHLORIDE; MAGNESIUM ION; MEVINOLIN; MINERAL; SEA WATER; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIATHEROGENIC ACTIVITY; ANTIHYPERTENSIVE ACTIVITY; AORTA ATHEROSCLEROSIS; ARTICLE; BLOOD PRESSURE REGULATION; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DILUTION; DRUG ACTIVITY; EVAPORATION; HARDNESS; HYPERCHOLESTEROLEMIA; HYPERTENSION; HYPOLIPEMIA; IN VIVO STUDY; LIPID BLOOD LEVEL; LIPID STORAGE; LOW TEMPERATURE; MALE; NONHUMAN; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS INHIBITION; RABBIT; RAT; SIGNAL TRANSDUCTION; SPONTANEOUSLY HYPERTENSIVE RAT; SYSTOLIC BLOOD PRESSURE;

ORYCTOLAGUS CUNICULUS; RATTUS;

EID: 84879493711     PISSN: None     EISSN: 16603397     Source Type: Journal    
DOI: 10.3390/md11062183     Document Type: Article

References (41)

1. Lusis, A.J. Atherosclerosis. Nature 2000, 407, 233-241.
2. Fruchart, J.C.; Duriez, P. High-density lipoproteins and coronary heart disease. Future prospects in gene therapy. Biochimie 1998, 80, 167-172. (Pubitemid 28185055)
3. Steinberg, D.; Parthasarathy, S.; Carew, T.E.; Khoo, J.C.; Witztum, J.L. Beyond cholesterol: Modifications of low-density lipoprotein that increase its atherogenicity. N. Engl. J. Med. 1989, 320, 915-924. (Pubitemid 19101597)
4. Yamada, Y.; Doi, T.; Hamakubo, T.; Kodama, T. Scavenger receptor family proteins: Roles for atherosclerosis, host defence and disorders of the central nervous system. Cell. Mol. Life Sci. 1998, 54, 628-640. (Pubitemid 28379666)
5. Escobar, E. Hypertension and coronary heart disease. J. Hum. Hypertens. 2002, 16, S61-S63. (Pubitemid 34441139)
6. Sacks, F.M.; Pfeffer, M.A.; Moye, L.A.; Rouleau, J.L.; Rutherford, J.D.; Cole, T.G.; Brown, L.; Warnica, J.W.; Arnold, J.M.; Wun, C.C.; et al. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels cholesterol and recurrent events trial investigators. N. Engl. J. Med. 1996, 335, 1001-1009.
7. Hardie, D.G.; Carling, D.; Carlson, M. The AMP-activated/SNF1 protein kinase subfamily: Metabolic sensors of the eukaryotic cell? Annu. Rev. Biochem. 1998, 67, 821-855. (Pubitemid 28411146)
8. Kemp, B.E.; Stapleton, D.; Campbell, D.J.; Chen, Z.P.; Murthy, S.; Walter, M.; Gupta, A.; Adams, J.J.; Katsis, F.; van Denderen, B.; et al. AMPK beta subunit targets metabolic stress sensing to glycogen. Biochem. Soc. Trans. 2003, 31, 162-168.
9. Towler, M.C.; Hardie, D.G. AMP-activated protein kinase in metabolic control and insulin signaling. Circ. Res. 2007, 100, 328-341.
10. Hardie, D.G. AMP-activated/SNF1 protein kinases: Conserved guardians of cellular energy. Nat. Rev. Mol. Cell Biol. 2007, 8, 774-785. (Pubitemid 47462132)
11. Hardie, D.G.; Pan, D.A. Regulation of fatty acid synthesis and oxidation by the AMP-activated protein kinase. Biochem. Soc. Trans. 2002, 30, 1064-1070. (Pubitemid 36002407)
12. Clarke, P.R.; Hardie, D.G. Regulation of HMG-CoA reductase: Identification of the site phosphorylated by the AMP-activated protein kinase in vitro and in intact rat liver. EMBO J. 1990, 9
13. An, Z.; Wang, H.; Song, P.; Zhang, M.; Geng, X.; Zou, M.H. Nicotine-induced activation of AMP-activated protein kinase inhibits fatty acid synthase in 3T3L1 adipocytes: A role for oxidant stress. J. Biol. Chem. 2007, 282, 26793-26801.
14. Fu, Z.Y.; Yang, F.L.; Hsu, H.W.; Lu, Y.F. Drinking deep seawater decreases serum total and low-density lipoprotein - Cholesterol in hypercholesterolemic subjects. J. Med. Food 2012, 15, 535-541.
15. Katsuda, S.; Yasukawa, T.; Nakagawa, K.; Miyake, M.; Yamasaki, M.; Katahira, K.; Mohri, M.; Shimizu, T.; Hazama, A. Deep-sea water improves cardiovascular hemodynamics in Kurosawa and Kusanagi-Hypercholesterolemic (KHC) rabbits. Biol. Pharm. Bull. 2008, 31, 38-44.
16. Hataguchi, Y.; Tai, H.; Nakajima, H.; Kimata, H. Drinking deep-sea water restores mineral imbalance in atopic eczema/dermatitis syndrome. Eur. J. Clin. Nutr. 2005, 59, 1093-1096. (Pubitemid 43118172)
17. Yoshikawa, S.; Hamada, A.; Gue, T.; Yokota, J.; Yamamoto, S.; Kusunose, M.; Miyamura, M.; Kyotani, S.; Kameda, R.; Tsutsui, Y.; et al. Pharmacological activity of deep-sea water: Examination of hyperlipemia prevention and medical treatment effect. Biol. Pharm. Bull. 2003, 26, 1552-1559.
18. Miyamura, M.; Yoshioka, S.; Hamada, A.; Takuma, D.; Yokota, J.; Kusunose, M.; Kyotani, S.; Kawakita, H.; Odani, K.; Tsutsui, Y.; et al. Difference between deep seawater and surface seawater in the preventive effect of atherosclerosis. Biol. Pharm. Bull. 2004, 27, 1784-1787.
19. Ma, J.; Folsom, A.R.; Melnick, S.L.; Eckfedlt, J.H.; Sharrett, A.R.; Nabulsi, A.A.; Hutchinson, R.G.; Metcalf, P.A. Association of serum and dietary magnesium with cardiovascular disease, hypertension, diabetes, insulin, and carotid arterial wall thickness: The ARIC study. J. Clin. Epidemiol. 1995, 48, 927-940.
20. Altura, B.T.; Brust, M.; Bloom, S.; Barbour, R.L.; Stempak, J.G.; Altura, B.M. Magnesium dietary intake modulates blood lipid levels and atherogenesis. Proc. Natl. Acad. Sci. USA 1990, 87, 1840-1844.
21. Olatunji, L.A.; Soladoye, A.O. Increased magnesium intake prevents hyperlipidemia and insulin resistance and reduces lipid peroxidation in fructose-fed rats. Pathophysiology 2007, 14, 11-15. (Pubitemid 46636221)
22. Ouchi, Y.; Tabata, R.E.; Stergiopoulos, K.; Sato, F.; Hattori, A.; Orimo, H. Effects of dietary magnesium on development of atherosclerosis in cholesterol-fed rabbits. Arteriosclerosis 1990, 10, 732-737. (Pubitemid 20273346)
23. Kishimoto, Y.; Tani, M.; Uto-Kondo, H.; Saita, E.; Iizuka, M.; Sone, H.; Yokota, K.; Kondo, K. Effects of magnesium on postprandial serum lipid responses in healthy human subjects. Br. J. Nutr. 2010, 103, 469-472.
24. Vaskonen, T.; Mervaala, E.; Seppänen-Laakso, T.; Karppanen, H. Diet enrichment with calcium and magnesium enhances the cholesterol-lowering effect of plant sterols in obese Zucker rats. Nutr. Metab. Cardiovasc. Dis. 2001, 11, 158-167.
25. Kass, L.; Weekes, J.; Carpenter, L. Effect of magnesium supplement on blood pressure: A meta-analysis. Eur. J. Clin. Nutr. 2012, 66, 411-418.
26. Itoh, K.; Kawasaka, T.; Nakamura, M. The effects of high oral magnesium supplement on blood pressure, serum lipids and related variables inapparently healthy Japanese subjects. Br. J. Nutr. 1997, 78
27. Laurant, P.; Kantelip, J.P.; Berthlot, A. Dietary magnesium supplement modifies blood pressure and cardiovascular function in mineralocorticoid-salt hypertensive rats but not in normotensive rats. J. Nutr. 1995, 125, 830-841.
28. Chung, I.M.; Yeo, M.A.; Kim, S.J.; Moon, H.I. Neuroprotective effects of resveratrol derivatives from the roots of Vitis thunbergii var. sinuate against glutamate-induced neurotoxicity in primary cultured rat cortical cells. Hum. Exp. Toxicol. 2011, 30, 404-408.
29. Pan, C.H.; Tsai, C.H.; Lin, W.H.; Chen, G.Y.; Wu, C.H. Ethanolic extract of Vitis thunbergii exhibits lipid lowering properties via modulation of the AMPK-ACC pathway in hypercholesterolemic rabbits. Evid. Based Complement. Alternat. Med. 2012, 2012, doi:10.1155/2012/436786.
30. Cholesterol Treatment Trialists' (CTT) Collaboration; Baigent, C.; Blackwell, L.; Emberson, J.; Holland, L.E.; Reith, C.; Bhala, N.; Peto, R.; Barnes, E.H.; Keech, A.; Simes, J.; et al. Efficacy and safety of more intensive lowering of LDL cholesterol: A meta-analysis of data from 170,000 participants in 26 randomised trials. Lancet 2010, 376, 1670-1681.
31. Yamaguchi, Y.; Kitagawa, S.; Kunitomo, M.; Fujiwara, M. Preventive effects of magnesium on raised serum lipid peroxide levels and aortic cholesterol deposition in mice fed an atherogenic diet. Magnes. Res. 1994, 7, 31-37.
32. King, J.L.; Miller, R.J.; Blue, J.P., Jr.; O'Brienm, W.D., Jr.; Erdman, J.W., Jr. Inadequate dietary magnesium intake increases atherosclerotic plaque development in rabbits. Nutr. Res. 2009, 29, 343-349.
33. Hwang, Y.P.; Choi, J.H.; Kim, H.G.; Khanal, T.; Song, G.Y.; Nam, M.S.; Lee, H.S.; Chung, Y.C.; Lee, Y.C.; Jeong, H.G. Saponins, especially platycodin D, from Platycodon grandiflorum modulate hepatic lipogenesis in high-fat diet-fed rats and high glucose-exposed HepG2 cells. Toxicol. Appl. Pharmacol. 2013, 267, 174-183.
34. Alberdi, G.; Rodríguez, V.M.; Macarulla, M.T.; Miranda, J.; Churruca, I.; Portillo, M.P. Hepatic lipid metabolic pathways modified by resveratrol in rats fed an obesogenic diet. Nutrition 2012, 29, 562-567.
35. Si, M.; Yan, Y.; Tang, L.; Wu, H.; Yang, B.; He, Q.; Wu, H. A novel indole derivative compound GY3 improves glucose and lipid metabolism via activation of AMP-activated protein kinase pathway. Eur. J. Pharmacol. 2013, 698, 480-488.
36. Das, S.; Cordis, G.A.; Maulik, N.; Das, D.K. Pharmacological preconditioning with resveratrol: Role of CREB-dependent Bcl-2 signaling via adenosine A3 receptor activation. Am. J. Physiol. Heart Circ. Physiol. 2005, 288, H328-H335. (Pubitemid 40023863)
37. Das, S.; Das, D.K. Resveratrol: A therapeutic promise for cardiovascular diseases. Recent Pat. Cardiovasc. Drug Discov. 2007, 2, 133-138.
38. Kirk, R.I.; Deitch, J.A.; Wu, J.M.; Lerea, K.M. Resveratrol decreases early signaling events in washed platelets but has little effect on platelet aggregation in whole blood. Blood Cells Mol. Dis. 2000, 26, 144-150. (Pubitemid 30604894)
39. Rudney, H.; Sexton, R.C. Regulation of cholesterol biosynthesis. Annu. Rev. Nutr. 1986, 6, 245-272.
40. Das, B.C.; Zhao, X.; Tang, X.Y.; Yang, F. Design, synthesis and biological study of pinacolyl boronate-substituted stilbenes as novel lipogenic inhibitors. Bioorg. Med. Chem. Lett. 2011, 21, 5638-5641.
41. Sheu, M.J.; Lin, H.Y.; Yang, Y.H.; Chou, C.J.; Chien, Y.C.; Wu, T.S.; Wu, C.H. Demethoxycurcumin, a major active curcuminoid from Curcuma longa, suppresses balloon injury induced vascular smooth muscle cell migration and neointima formation: An in vitro and in vivo study. Mol. Nutr. Food Res. 2013, doi:10.1002/mnfr.201200462.